Stocks / NYSE / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

Our Opinion

Bristol-Myers Squibb Company is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Evidence:

In the following press release company announced, “FDA Approves ERBITUX(R) (cetuximab) as First-Line Treatment in KRAS Mutation-Negative (Wild-Type) Epidermal Growth Factor Receptor (EGFR)-Expressing Metastatic Colorectal Cancer in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, Leucovorin)”. Read the full article.

Some news items:

Scalded to Death at Bristol-Myers Squibb – by PETA.

Company Description

Bristol-Myers Squibb Co. operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. [Source: MarketWatch]

Website: http://www.bms.com